IDF Europe is part of EU Horizon 2020-funded project “ISLET – Advancing Innovative Stem Cell-based Therapy for Diabetes in Europe”. The project aims to build and implement a new and innovative programme for producing and marketing human pluripotent stem cell (hPSC)-derived advanced therapy medicinal products (ATMPs) for the treatment of people with T1D.
Within this project, we initiated a dialogue between scientists and young PwD to explore the best ways of broadening understanding of scientific research among the general public. As part of this, we produced a blog post which lists the main questions young people living with diabetes asked of the scientists, both looking at the potential of the ISLET project as well as the scientists’ own interests and motivation when conducting research.
Click here to read the blog post
